Yayınlar & Eserler

Yayın Ağı
Makaleler 15
Tümü (15)
SCI-E, SSCI, AHCI (13)
SCI-E, SSCI, AHCI, ESCI (13)
Scopus (13)
TRDizin (4)
Diğer Yayınlar (1)

1. The role of CD40L-expressing CXCR5+CD8+ follicular cytotoxic T cells in chronic lymphocytic leukemia

Akboga F., Hindilerden F., Hindilerden I. Y., Gulturk E., DENİZ G., GELMEZ M. Y.
Immunologic Research , cilt.73, sa.1, 2025 (SCI-Expanded) identifier identifier identifier

2. Real-world data on direct oral anticoagulants in BCR::ABL1-negative myeloproliferative neoplasms (MPNs): a multicenter retrospective study on behalf of scientific subcommittee on MPNs for Turkish society of hematology

Baysal M., Aksoy E., Bedir K. H., ÖZMEN İBİŞ D., Patır P., Demirci U., et al.
Journal of Thrombosis and Thrombolysis , cilt.58, sa.2, ss.284-298, 2025 (SCI-Expanded) identifier identifier

3. Comparison of different plerixafor-based strategies for adequate hematopoietic stem cell collection in poor mobilizers

Sadri S., Yonal-Hindilerden I., mutlu Y. g., tiryaki t. o., Gemici A., Beköz H. S., et al.
The European Research Journal , cilt.9, sa.6, ss.1368-1379, 2023 (Hakemli Dergi) Creative Commons License identifier

4. Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients: The Roles of PLASMIC and French Scores İleri Yaştaki İmmün Trombotik Trombositopenik Purpura Hastalarında; PLASMIC ve French Skorlamalarının Rolü

Baysal M., Hindilerden F., ÜMİT E. G., DEMİR A. M., Karadağ F. K., Saydam G., et al.
Turkish Journal of Hematology , cilt.40, sa.4, ss.251-257, 2023 (SCI-Expanded) Creative Commons License identifier identifier

5. The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL

Akpinar S., Dogu M. H., ÇELİK S., Ekinci O., Hindilerden I. Y., Dal M. S., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.22, sa.3, ss.169-173, 2022 (SCI-Expanded) identifier identifier identifier

6. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

CİVRİZ BOZDAĞ S., CENGİZ SEVAL G., Hindilerden I. Y., Hindilerden F., ANDIÇ N., BAYDAR M., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.39, sa.1, ss.43-54, 2022 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier identifier

7. Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients

Ulu B. U., Dal M. S., Hindilerden I. Y., Akay O. M., MEHTAP Ö., Buyukkurt N., et al.
JOURNAL OF CHEMOTHERAPY , cilt.34, sa.3, ss.190-198, 2022 (SCI-Expanded) identifier identifier identifier

8. Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma

Yonal-Hindilerden I., Hindilerden F., Mastanzade M., Tiryaki T. O., Tasan-Yenigun S., BİLEN Y., et al.
FRONTIERS IN ONCOLOGY , cilt.11, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

9. Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection

Hindilerden F., Hindilerden I. Y., Kucukkaya R. D.
BALKAN MEDICAL JOURNAL , cilt.38, sa.2, ss.141-142, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier identifier

10. Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case

Hindilerden F., Yonal-Hindilerden I., Akar E., Kart-Yasar K.
THROMBOSIS RESEARCH , cilt.195, ss.136-138, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

11. The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms

Yonal-Hindilerden I., Sahin E., Hindilerden F., Daglar-Aday A., Nalcaci M.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.20, 2020 (SCI-Expanded) identifier

12. The Clinical Significance of JAK2V617F Mutational Status on Phenotypic Features in Philadelphia-Negative Chronic Myeloproliferative Neoplasms

Sahin E., Yonal-Hindilerden I., Hindilerden F., Daglar-Aday A., Nalcaci M.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.20, 2020 (SCI-Expanded) identifier

13. Severe Autoimmune Hemolytic Anemia in COVID-19 Infection, Safely Treated with Steroids

Hindilerden F., Yonal-Hindilerden I., Akar E., Yesilbag Z., Kart-Yasar K.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , cilt.12, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

14. Immune Thrombocytopenia in a Very Elderly Patient With Covid-19

Hindilerden F., Yonal-Hindilerden I., Sevtap S., Kart-Yasar K.
FRONTIERS IN MEDICINE , cilt.7, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

15. The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis.

YONAL-HINDILERDEN I., Daglar-Aday A., HINDILERDEN F., AKADAM-TEKER B., YILMAZ C., NALCACI M., et al.
Journal of clinical medicine research , cilt.8, ss.29-39, 2016 (Hakemli Dergi) identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 1

1. Outcome of mycophenolate mophetil treatment in patients with proliferative lupus nephritis.

ARTIM ESEN B., ÖZLÜK M. Y., KILIÇASLAN I., HİNDİLERDEN F., KAMALI S., GÜL A., et al.
The 19th International Congress on SLE, Vancouver, Kanada, 24 - 27 Haziran 2010, ss.169, (Tam Metin Bildiri)
Metrikler

Yayın

16

Yayın (WoS)

13

Yayın (Scopus)

13

Atıf (WoS)

5

H-İndeks (WoS)

1

Atıf (Scopus)

3

H-İndeks (Scopus)

1

Açık Erişim

3
BM Sürdürülebilir Kalkınma Amaçları